Delaying Bone Drugs After Cancer Spreads to Bone Nearly Doubles Fracture Risk, Study Finds
A retrospective landmark and propensity score–matched analysis found that delaying bone-modifying agent therapy beyond six months after a bone metastasis ...
A retrospective landmark and propensity score–matched analysis found that delaying bone-modifying agent therapy beyond six months after a bone metastasis ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.